Sanofi’s efdoralprin alfa earns orphan designation in the EU for alpha-1 antitrypsin deficiency related emphysema Additional orphan designation reinforces Sanofi’s commitment to developing treatments ...

Spectrum Health is one of the first hospitals in Michigan to offer a novel treatment for emphysema. The treatment uses the Zephyr® Valve system, an FDA-approved minimally invasive procedure requiring ...

Emphysema, a disease that destroys air sacs in lungs, made it difficult for Linda Sachs to breathe, which impacted her career at a radio station. However, a new treatment from the University of ...

PHILADELPHIA (WPVI) -- For people with emphysema, breathing in is hard because the lungs can't expand properly. In this week's Moves in Medicine, we learn about a procedure letting some emphysema ...

Doctors at Temple Health recently completed a study that led to a breakthrough treatment for severe emphysema, the first treatment of its kind approved by the FDA. Emphysema is a type of chronic ...

TORONTO, May 28 (UPI) --Injecting the Alpha-1 antitrypsin, or AAT, protein into patients with genetically-caused emphysema has been shown as an effective treatment that slows the progression of the ...

A unique engineering perspective of emphysema progression in the lung suggests how mechanisms operating at the micromechanical scale could help to predict patient survival and quality of life ...

The symptoms of COPD aren’t always obvious. Subtle signs like finding it harder to keep up with friends on a walk or unconsciously cutting down on physical activity can be easy to miss. Some people ...

The market size for emphysema in the leading markets is expected to grow significantly by 2034. The United States accounted for the highest emphysema treatment market size in 7MM in 2024, in ...

PULMONARY emphysema is one of the most common, disabling and chronically progressive diseases seen in a general hospital. The usual sequence of emphysema, bronchitis, fibrosis and progressive ...